Spastic Paraplegia Epilepsy Mental Retardation  >>  Ovidrel (choriogonadotropin alfa)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ovidrel (choriogonadotropin alfa) / EMD Serono
EXPRESS, NCT01210144 / 2007-003938-41: EXpression PRofile Endometrium Samples Study

Terminated
4
27
Europe
Gonal -f® [r-hFSH], Gonal-f®, Follitropin Alfa, Ovitrelle® [r-hCG alfa], Ovitrelle®, Ovidrel®, Gonadotropin-releasing hormone (GnRH) Agonist, Gonadotropin-releasing hormone (GnRH) Antagonist
Merck KGaA, Darmstadt, Germany, Merck Serono S.A.S, France
In Vitro Fertilization
08/10
08/10

Download Options